Legal Entity
IQVIA SOLUTIONS ASIA
Country of registration | Singapore |
Registration number | 198600924Z |
Incorporation date | 6 May 1986 |
Company age | 39 years 10 months |
Official entity type | Private Limited Company |
No. of officers | 34 |
Contact
79 ANSON ROAD, #19-01, Singapore 079906
This is the legal entity page of IQVIA SOLUTIONS ASIA. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- IQVIAView MoreUnited States of AmericaIQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
- IMS HEALTHView MoreUnited States of AmericaIQVIA is a leading global provider of data, technology, and consulting services to the healthcare and life sciences industries. Following the merger of IMS Health and Quintiles, we offer a comprehensive suite of solutions that enable our clients to innovate, optimize, and grow their businesses. Our services include market research, clinical trial management, and commercialization strategies, all powered by advanced analytics and insights. Visit our new website at www.iqvia.com to learn more.
- IQVIA MIDDLE EAST AND AFRICAView MoreUnited Arab EmiratesIQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit
- IQVIA ASIA PACIFICView MoreSingaporeIQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Our Human Data Science approach enables life sciences companies to innovate with confidence, maximize opportunities, and drive human health outcomes forward. We leverage domain expertise, advanced analytics, unparalleled data, and transformative technology to provide actionable solutions and help stakeholders make better, more insightful decisions.
Fiscal/Budgeting Period | October - December |
Auditor | FORVIS MAZARS LLP |
Revenue | 26m - 50m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 100,000 |
Frequently Asked Questions (FAQ)
- What is the address of IQVIA SOLUTIONS ASIA?
- Where is IQVIA SOLUTIONS ASIA's headquarter?
- What is IQVIA SOLUTIONS ASIA's contact number?
- What IQVIA SOLUTIONS ASIA's spending power?
- Does IQVIA SOLUTIONS ASIA have a presence in the domain it operates in?

